Abbott just announced a “medical device correction” for approximately three million glucose sensor monitors in the U.S., ...

The correction is one of the largest in Abbott's recent continuous glucose monitor business, which dominates the global ...

Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring ...

Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors ...

Abbot has issued a medical device correction for some of its glucose sensor products after identifying a manufacturing issue that can lead to falsely low glucose readings. The correction affects about ...

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, ...

These two medical device makers have seen huge success in their areas of specialty. DexCom has a profitable and growing CGM business, and its addressable market is expanding. Abbott sells ...

Global Insulin Delivery Device Market Growth Overview The global insulin delivery device market is poised to expand at a CAGR of around 8% during the forecast period, driven by the increasing global ...

Wondering if MercadoLibre stock is a true value opportunity or just riding a wave of hype? You are not alone, and digging into its fundamentals is the best way to get clarity. While the stock is up 16 ...

Joining the American Association of Retired Persons (AARP) might be the best bang for your buck in retirement. Memberships ...